痛風の有無にかかわらず高尿酸血症におけるFYU-981の研究

基本情報

NCT ID

NCT02416167

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

200

治験依頼者名

Fuji Yakuhin Co., Ltd.

概要

The purpose of this study is confirmatory investigation of safety and efficacy (dose response and optimal dose according to the percent reduction from baseline in serum urate level at the final visit) of FYU-981 administered orally to hyperuricemic patients with and without gout for 12 weeks (dose-escalating initial period: 4 weeks followed by maintenance period: 8 weeks) by the method of randomized (dynamic allocation), placebo-controlled, double-blind, parallel group comparison.

対象疾患

介入

依頼者（Sponsor）